The search for tumor-specific targets among membrane proteins is important for the development for new effective anticancer drugs because membrane proteins represent 60% of drug targets. Transmembrane proteins in cancer cells exhibit an altered pattern of post-translational modifications and generally contain a large extracellular domains with multiple glycosylation and sulfhydryl sites with unknown function. We analyze the features of membrane protein which are required for recognition by monoclonal antibodies using the sodium-dependent phosphate transporter NaPi2b, containing a large extracellular domain 4 (EMD4, 250-360 a.a.) with 4 cysteines and 6 potential asparagine-linked glycosylation sites which can potentially contribute to foldability of conformationally exposed epitope corresponding to this domain.